3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
4
Motor Activity
3
Head and Neck Neoplasms
3
Breast Neoplasms
3
Pharyngeal Neoplasms
2
Obesity
2
Laryngeal Neoplasms
2
Diabetes Mellitus, Type 2
2
Colonic Neoplasms
2
Weight Loss
1
Sarcopenia
1
Lung Neoplasms
1
Lung Diseases
1
Liver Neoplasms
1
Liver Diseases
1
Gastrointestinal Neoplasms
1
Chronic Disease
1
COVID-19
1
Brain Neoplasms
1
Body Weight Changes
1
Interventions
Resistance Training
3
Exercise
2
Docosahexaenoic Acids
2
pembrolizumab
1
durvalumab
1
atezolizumab
1
Ultrasonography
1
Standard of Care
1
Preoperative Exercise
1
Olive Oil
1
Nutritional Status
1
Nutrition Assessment
1
Nivolumab
1
Immune Checkpoint Inhibitors
1
Hepatectomy
1
Goserelin
1
Gonadotropin-Releasing Hormone
1
Gastrectomy
1
Esophagectomy
1
Drug Therapy
1
Control Groups
1
Colectomy
1
Chemotherapy, Adjuvant
1
CP protocol
1
4-azidosalicylic acid-phosphatidylserine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcopenia
×
Nutritional Status
×
Clear all
NCT05281211
2025-04-18
NEXPREM
San Camillo Hospital, Rome
Phase NA
Completed
70 enrolled